# Prytime Medical Devices, Inc.

> Prytime Medical Devices makes balloon catheters, access kits and simulators for clinicians treating severe internal bleeding. Its pREBOA-PRO catheter is designed for controlled partial aortic occlusion, allowing some blood to pass while a team works toward definitive hemorrhage control. The Boerne, Texas company sells into trauma, obstetric and military medicine and trains clinicians to use its devices.

- **Founded:** 2014
- **Headquarters:** Boerne, United States
- **Founders:** David Spencer (Founder and CEO)
- **Products:** ER-REBOA Catheter, ER-REBOA PLUS Catheter, pREBOA-PRO Catheter, REBOA Catheter Convenience Set, ARTI-PRO Simulator
- **Notable:** Original ER-REBOA catheter received FDA 510(k) clearance in 2015., Prytime reported the 500th pREBOA-PRO patient case in December 2023., pREBOA-PRO gained CE marking before its first reported civilian European use in January 2025.

## Products & services

- **ER-REBOA Catheter** — Original 7 Fr compatible aortic balloon occlusion catheter used in emergency hemorrhage control.
- **ER-REBOA PLUS Catheter** — Updated REBOA catheter with placement markers and central aortic pressure monitoring.
- **pREBOA-PRO Catheter** — 7 Fr compatible catheter designed for pressure-guided partial aortic occlusion and distal blood flow.
- **REBOA Catheter Convenience Set** — Vascular access and fixation components packaged for REBOA placement.
- **ARTI-PRO Simulator** — Physical simulator for arterial access, catheter placement and balloon occlusion practice with simulated pressure feedback.

## Achievements

- Original ER-REBOA catheter received FDA 510(k) clearance in 2015.
- Prytime reported the 500th pREBOA-PRO patient case in December 2023.
- pREBOA-PRO gained CE marking before its first reported civilian European use in January 2025.
- An October 2025 FDA 510(k) clearance expanded the pREBOA-PRO labeled Zone 1 occlusion duration to two hours.

## Latest updates

- **2025-10** — Prytime announced an FDA 510(k) clearance expanding pREBOA-PRO's labeled Zone 1 occlusion duration to two hours.
- **2025-01** — The company reported the first civilian European use of pREBOA-PRO after CE marking.
- **2024-02** — Prytime announced medical products and training donated to Ukraine valued at more than $1.75 million.

## Links

- Website: https://prytimemedical.com/
- LinkedIn: https://www.linkedin.com/company/prytime-medical-devices-inc-
- Twitter/X: https://twitter.com/prytimemedical
- YouTube: https://www.youtube.com/channel/UC9szqdo-oos2G73Ur6H1CqA/videos
- Facebook: https://www.facebook.com/Prytimemedical/

---

Profile page: https://yespress.io/prytime-medical-devices-inc
Published by YesPress — https://yespress.io
Last updated: 2026-09-29